According to research firms Visiongain and iData research, the global market for gastrointestinal medical devices will reach $18.2 billion 2015(1) with nearly 25 percent of that consumed within gastrointestinal endoscopic devices worldwide by 2020(2).
Starting Saturday, October 16 in sunny Honolulu, industry leaders across the spectrum of gastroenterology and GI will gather at ACG 2015, the American College of Gastroenterology Annual Scientific Meeting & Postgraduate Course. T3 Labs’ Program Director of Training and Education Kelley Bennett and Program Manager Matt Elder will be onsite learning about the latest innovations and techniques in gastroenterology while connecting with clinicians, device manufacturers and their sales teams seeking the best in medical device testing and training.
“Our medical device testing and training programs make the most efficient use of our sponsors investment in preclinical and training,” Kelley said. “We have multiple gastro and GI sponsors with products in the development process including graspers for dissections and biopsy forceps in the exploratory, education and ‘voice of the customer’ stage, as well as a hemostatic agent for the GI system that has gone the full device development and evaluation track with T3 and is nearing its GLP study for FDA regulatory approval.”
The top 3 ACG 2015 program elements Kelley has her eye on:
- “How Information Technology Will Transform Gastroenterology,” Featured Lecture, October 19, 1:15 p.m. – 2:10 p.m., Kalakaua Ballroom B – New technological innovations including “wireless biosensors to track physiology remotely and in real time” is right in our wheelhouse.
- Posters and Presentations, October 18, 2:30 – 4:30 – The front lines of what’s next in gastro innovation.
- ACG Publishing Symposium, Monday, October 19, 11:40 a.m. – 12:40 p.m., Room 313C – Research publishing tips from the editors of The American Journal of Gastroenterology, Clinical and Translational Gastroenterology, and ACG Case Reports Journal are certain to expand our capabilities to enhance the support we provide to our gastro and GI preclinical medical device testing and training sponsors.
Located in Atlanta just 20 minutes from Hartsfield-Jackson International Airport, T3 Labs is an industry leader in preclinical medical device testing and training. T3 has archived more than 50 GLP studies and more than 30 T3 sponsors’ devices have achieved their FDA clearance.
From concept to cure, T3’s seven state of the art procedure areas, three top quality operating rooms and “concierge” level of service and support for medical device training programs are chosen time after time by innovative companies and their sales teams like J&J, Biosense Webster, Surefire Medical and more for their preclinical medical device testing and training needs.
One seamless preclinical CRO experience
If you are evaluating the feasibility or voice of the customer for a new device for gastro, if you are ready for preclinical testing, or if you are seeking the best in training for your affiliated physicians, surgeons or sales teams, T3 Labs is a full service CRO that provides one seamless preclinical testing and training experience in the most efficient model, animal or cadaveric, you might require.
- Global Gastrointestinal Devices Market Will Reach $18.2 Billion In 2015 Predicts New Visiongain [report].
- $4.4 Billion Gastrointestinal Endoscopic Market in the U.S. and Europe Projected for 2020.